MMCM
EMN icon

Murphy & Mullick Capital Management’s Eastman Chemical EMN Stock Holding History

Murphy & Mullick Capital Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$64 – 743
2025
Q4 		$64 Buy
+1
New +$62 ﹤0.01% 806

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Murphy & Mullick Capital Management's EMN Position: Q1 2026 in Review

Murphy & Mullick Capital Management sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 1 share — an estimated $64 sold.

Murphy & Mullick Capital Management first reported a position in EMN in Q4 2025 and held it in 1 quarter. The position peaked at $64 in Q4 2025. 640 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Murphy & Mullick Capital Management reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • Murphy & Mullick Capital Management sold 1 Eastman Chemical share in Q1 2026, an estimated $64.
  • Murphy & Mullick Capital Management first reported a position in Eastman Chemical in Q4 2025 and held it in 1 quarter.
  • Murphy & Mullick Capital Management's Eastman Chemical position peaked at $64 in Q4 2025.
  • 640 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.